Fenghong Liu1, Shu Ng2, Florence Huguet3, Ellen D Yorke1, Gikas S Mageras1, Karyn A Goodman2. 1. a Department of Medical Physics , Memorial Sloan Kettering Cancer Center , New York , New York , USA ; 2. b Department of Radiation Oncology , Memorial Sloan Kettering Cancer Center , New York , New York , USA ; 3. c Department of Radiation Oncology , Hôpital Tenon , Paris , France.
Abstract
BACKGROUND: Radiation therapy (RT) is an integral component of the management of gastroesophageal junction (GEJ) tumors. We evaluated the use of implanted radiopaque fiducials as tumor surrogates to allow for more focal delivery of RT to these mobile tumors when using respiratory gating (RG) to reduce motion. MATERIAL AND METHODS: We analyzed four-dimensional computed tomography scans of 20 GEJ patients treated with RG and assessed correlation between tumor and implanted fiducial motion over the whole respiratory cycle and within a clinically realistic gate around end-exhalation. We evaluated fiducial motion concordance in 11 patients with multiple fiducials. RESULTS: Gating reduced anterior-posterior (AP) and superior-inferior (SI) mean tumor and fiducial motions by over 50%. Fiducials and primary tumor motions were moderately correlated: R(2) for AP and SI linear fits to the entire group were 0.54 and 0.68, respectively, but the correlation had strong inter-patient variation. For all patients with multiple fiducials, relative in-gate displacements were below 3 mm; results were similar for eight of 11 patients over the whole cycle. CONCLUSION: Implanted fiducial and gross tumor volume (GTV) motions correlate well but the correlation is patient-specific and may be dependent on the location of the fiducials with respect to the GTV.
BACKGROUND: Radiation therapy (RT) is an integral component of the management of gastroesophageal junction (GEJ) tumors. We evaluated the use of implanted radiopaque fiducials as tumor surrogates to allow for more focal delivery of RT to these mobile tumors when using respiratory gating (RG) to reduce motion. MATERIAL AND METHODS: We analyzed four-dimensional computed tomography scans of 20 GEJ patients treated with RG and assessed correlation between tumor and implanted fiducial motion over the whole respiratory cycle and within a clinically realistic gate around end-exhalation. We evaluated fiducial motion concordance in 11 patients with multiple fiducials. RESULTS: Gating reduced anterior-posterior (AP) and superior-inferior (SI) mean tumor and fiducial motions by over 50%. Fiducials and primary tumor motions were moderately correlated: R(2) for AP and SI linear fits to the entire group were 0.54 and 0.68, respectively, but the correlation had strong inter-patient variation. For all patients with multiple fiducials, relative in-gate displacements were below 3 mm; results were similar for eight of 11 patients over the whole cycle. CONCLUSION: Implanted fiducial and gross tumor volume (GTV) motions correlate well but the correlation is patient-specific and may be dependent on the location of the fiducials with respect to the GTV.
Authors: Christopher J DiMaio; Satish Nagula; Karyn A Goodman; Alice Y Ho; Arnold J Markowitz; Mark A Schattner; Hans Gerdes Journal: Gastrointest Endosc Date: 2010-06 Impact factor: 9.427
Authors: Christopher Nelson; Peter Balter; Rodolfo C Morice; Kara Bucci; Lei Dong; Susan Tucker; Sastry Vedam; Joe Y Chang; George Starkschall Journal: Int J Radiat Oncol Biol Phys Date: 2010-02-04 Impact factor: 7.038
Authors: Kuai-le Zhao; Zhongxing Liao; M Kara Bucci; Ritsuko Komaki; James D Cox; Zhiqian H Yu; Lifei Zhang; Radhe Mohan; Lei Dong Journal: Radiother Oncol Date: 2007-08-22 Impact factor: 6.280
Authors: Oscar Matzinger; Erich Gerber; Zvi Bernstein; Philippe Maingon; Karin Haustermans; Jean François Bosset; Akos Gulyban; Philip Poortmans; Laurence Collette; Abraham Kuten Journal: Radiother Oncol Date: 2009-04-15 Impact factor: 6.280
Authors: Russell E Kincaid; Agung E Hertanto; Yu-Chi Hu; Abraham J Wu; Karyn A Goodman; Hai D Pham; Ellen D Yorke; Qinghui Zhang; Qing Chen; Gig S Mageras Journal: Acta Oncol Date: 2018-01-19 Impact factor: 4.089